Search

STAAR Surgical Co

Затворен

СекторЗдравеопазване

26.14 3.36

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

24.7

Максимум

26.2

Ключови измерители

By Trading Economics

Приходи

5.2M

5.2M

Продажби

36M

94M

EPS

-0.23

Марж на печалбата

5.567

Служители

921

EBITDA

19M

10M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+18.44% upside

Дивиденти

By Acuity

Следващи печалби

3.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-135M

1.3B

Предишно отваряне

22.78

Предишно затваряне

26.14

Настроения в новините

By Acuity

23%

77%

79 / 340 Класиране в Healthcare

STAAR Surgical Co Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.08.2026 г., 23:46 ч. UTC

STAAR Surgical Co. shares declined after-market, reflecting broader market sentiment amid an unexpected drop in U.S. retail sales for July.

13.08.2026 г., 20:02 ч. UTC

Social Media
News

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

12.08.2026 г., 23:56 ч. UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

11.08.2026 г., 20:01 ч. UTC

News

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

10.08.2026 г., 20:02 ч. UTC

Social Media
News

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

7.08.2026 г., 22:56 ч. UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

6.08.2026 г., 20:03 ч. UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

5.08.2026 г., 20:02 ч. UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

4.08.2026 г., 19:51 ч. UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

3.08.2026 г., 20:03 ч. UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

31.07.2026 г., 19:52 ч. UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

30.07.2026 г., 19:29 ч. UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

29.07.2026 г., 22:11 ч. UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

28.07.2026 г., 18:56 ч. UTC

News

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

27.07.2026 г., 19:07 ч. UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

22.07.2026 г., 18:11 ч. UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21.07.2026 г., 16:56 ч. UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20.07.2026 г., 20:01 ч. UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Сравнение с други в отрасъла

Ценова промяна

STAAR Surgical Co Прогноза

Ценова цел

By TipRanks

18.44% нагоре

12-месечна прогноза

Среден 30 USD  18.44%

Висок 40 USD

Нисък 20 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за STAAR Surgical Co през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

7 ratings

2

Купи

4

Задържане

1

Продай

Настроение

By Acuity

79 / 340 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat